<?xml version="1.0"?><!-- generator="bbPress" -->

<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
>

<channel>
<title>Library Home Forum: Medicines - BRMs (Biologic Response Modifiers) - Recent Posts</title>
<link>http://www.rheumatoidarthritisguy.com/library/</link>
<description>Library Home Forum: Medicines - BRMs (Biologic Response Modifiers) - Recent Posts</description>
<language>en</language>
<pubDate>Sat, 11 Feb 2012 17:34:15 +0000</pubDate>

<item>
<title>RA Guy on "Rituximab (Rituxan)"</title>
<link>http://www.rheumatoidarthritisguy.com/library/topic/rituximab-rituxan#post-330</link>
<pubDate>Sat, 24 Oct 2009 09:13:33 +0000</pubDate>
<dc:creator>RA Guy</dc:creator>
<guid isPermaLink="false">330@http://www.rheumatoidarthritisguy.com/library/</guid>
<description>&#60;p&#62;&#60;strong&#62;Brain Disease Found in 3rd Patient on Roche’s Rituxan&#60;/strong&#62;&#60;/p&#62;
&#60;p&#62;A third arthritis patient taking Roche Holding AG and Biogen Idec Inc.’s Rituxan developed a rare and potentially fatal brain disorder, U.S. regulators said.&#60;/p&#62;
&#60;p&#62;The 73-year-old patient, diagnosed three years ago with rheumatoid arthritis, was treated with Rituxan in February 2009, according to a letter to physicians from Biogen and Roche’s Genentech unit. She developed symptoms four to six months later and was diagnosed with the brain infection known as PML, or progressive multifocal leukoencephalopathy, according to a statement from the U.S. Food and Drug Administration. &#60;/p&#62;
&#60;p&#62;Read More: &#60;a href=&#34;http://www.bloomberg.com/apps/news?pid=20601103&#38;#038;sid=a.soONQKbh5g&#34; rel=&#34;nofollow&#34;&#62;http://www.bloomberg.com/apps/news?pid=20601103&#38;#038;sid=a.soONQKbh5g&#60;/a&#62;
&#60;/p&#62;</description>
</item>
<item>
<title>RA Guy on "Abatacept (Orencia)"</title>
<link>http://www.rheumatoidarthritisguy.com/library/topic/abatacept-orencia#post-302</link>
<pubDate>Wed, 26 Aug 2009 11:52:36 +0000</pubDate>
<dc:creator>RA Guy</dc:creator>
<guid isPermaLink="false">302@http://www.rheumatoidarthritisguy.com/library/</guid>
<description>&#60;p&#62;&#60;strong&#62;Bristol-Myers says FDA broadens label for Orencia&#60;/strong&#62;&#60;/p&#62;
&#60;p&#62;NEW YORK -- Bristol-Myers Squibb Co. said Wednesday regulators approved a change in the labeling of the rheumatoid arthritis drug Orencia.&#60;/p&#62;
&#60;p&#62;The FDA approved an addition to the label that says studies show Orencia is effective for patients who have had the disease for two years or less.&#60;/p&#62;
&#60;p&#62;Read More: &#60;a href=&#34;http://www.forbes.com/feeds/ap/2009/08/26/business-health-care-us-bristol-myers-squibb-orencia_6817041.html&#34; rel=&#34;nofollow&#34;&#62;http://www.forbes.com/feeds/ap/2009/08/26/business-health-care-us-bristol-myers-squibb-orencia_6817041.html&#60;/a&#62;
&#60;/p&#62;</description>
</item>
<item>
<title>RA Guy on "- General Questions"</title>
<link>http://www.rheumatoidarthritisguy.com/library/topic/-general-questions#post-91</link>
<pubDate>Sun, 02 Aug 2009 09:49:37 +0000</pubDate>
<dc:creator>RA Guy</dc:creator>
<guid isPermaLink="false">91@http://www.rheumatoidarthritisguy.com/library/</guid>
<description>&#60;p&#62;Information, questions and answers related to: General Questions.
&#60;/p&#62;</description>
</item>
<item>
<title>RA Guy on "Abatacept (Orencia)"</title>
<link>http://www.rheumatoidarthritisguy.com/library/topic/abatacept-orencia#post-90</link>
<pubDate>Sun, 02 Aug 2009 09:48:36 +0000</pubDate>
<dc:creator>RA Guy</dc:creator>
<guid isPermaLink="false">90@http://www.rheumatoidarthritisguy.com/library/</guid>
<description>&#60;p&#62;Information, questions and answers related to: Abatacept (Orencia).
&#60;/p&#62;</description>
</item>
<item>
<title>RA Guy on "Rituximab (Rituxan)"</title>
<link>http://www.rheumatoidarthritisguy.com/library/topic/rituximab-rituxan#post-89</link>
<pubDate>Sun, 02 Aug 2009 09:47:13 +0000</pubDate>
<dc:creator>RA Guy</dc:creator>
<guid isPermaLink="false">89@http://www.rheumatoidarthritisguy.com/library/</guid>
<description>&#60;p&#62;Information, questions and answers related to: Rituximab (Rituxan).
&#60;/p&#62;</description>
</item>
<item>
<title>RA Guy on "Anakinra (Kineret)"</title>
<link>http://www.rheumatoidarthritisguy.com/library/topic/anakinra-kineret#post-88</link>
<pubDate>Sun, 02 Aug 2009 09:46:22 +0000</pubDate>
<dc:creator>RA Guy</dc:creator>
<guid isPermaLink="false">88@http://www.rheumatoidarthritisguy.com/library/</guid>
<description>&#60;p&#62;Information, questions and answers related to: Anakinra (Kineret)
&#60;/p&#62;</description>
</item>
<item>
<title>RA Guy on "Adalimumab (Humira)"</title>
<link>http://www.rheumatoidarthritisguy.com/library/topic/adalimumab-humira#post-87</link>
<pubDate>Sun, 02 Aug 2009 09:45:18 +0000</pubDate>
<dc:creator>RA Guy</dc:creator>
<guid isPermaLink="false">87@http://www.rheumatoidarthritisguy.com/library/</guid>
<description>&#60;p&#62;Information, questions and answers related to: Adalimumab (Humira).
&#60;/p&#62;</description>
</item>
<item>
<title>RA Guy on "Infliximab (Remicade)"</title>
<link>http://www.rheumatoidarthritisguy.com/library/topic/infliximab-remicade#post-86</link>
<pubDate>Sun, 02 Aug 2009 09:44:24 +0000</pubDate>
<dc:creator>RA Guy</dc:creator>
<guid isPermaLink="false">86@http://www.rheumatoidarthritisguy.com/library/</guid>
<description>&#60;p&#62;Information, questions and answers related to: Infliximab (Remicade).
&#60;/p&#62;</description>
</item>
<item>
<title>RA Guy on "Etanercept (Enbrel)"</title>
<link>http://www.rheumatoidarthritisguy.com/library/topic/etanercept-enbrel#post-85</link>
<pubDate>Sun, 02 Aug 2009 09:43:31 +0000</pubDate>
<dc:creator>RA Guy</dc:creator>
<guid isPermaLink="false">85@http://www.rheumatoidarthritisguy.com/library/</guid>
<description>&#60;p&#62;Information, questions and answers related to: Etanercept (Enbrel).
&#60;/p&#62;</description>
</item>

</channel>
</rss>

